Clinical Trial Update: Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial evaluating tirofiban to prevent early neurological deterioration after intravenous thrombolysis in acute ischemic stroke. Recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Infarction
• Stroke

Drugs mentioned

• Aggrastat (tirofiban)

Snippet

Sponsor: Capital Medical University | Conditions: Acute Stroke, Ischemic Stroke, Acute | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING